These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 18904811)

  • 41. Treatment of the leukemias and lymphomas; current trends.
    SYKES MP
    J Am Med Womens Assoc; 1952 Sep; 7(9):321-5. PubMed ID: 12990488
    [No Abstract]   [Full Text] [Related]  

  • 42. Current views concerning the nature of management of leukemia and allied disorders.
    WINTROBE MM
    Am Pract Dig Treat; 1950 Jan; 1(1):68-74. PubMed ID: 15403176
    [No Abstract]   [Full Text] [Related]  

  • 43. Current views concerning the nature and management of leukemia and allied disorders.
    WINTROBE MM
    Proc Inst Med Chic; 1949 May; 17(14):318-28. PubMed ID: 18129996
    [No Abstract]   [Full Text] [Related]  

  • 44. Trends in therapy and survival of patients suffering from leukemias and lymphomas.
    Rohn RJ; Donlan EJ
    Proc Natl Cancer Conf; 1964; 5():663-70. PubMed ID: 5856195
    [No Abstract]   [Full Text] [Related]  

  • 45. Malignant lymphomas and leukemias.
    CARROLL DS
    J La State Med Soc; 1958 May; 110(5):154-60. PubMed ID: 13525884
    [No Abstract]   [Full Text] [Related]  

  • 46. [Long-term therapy in leukemias and malignant lymphomas].
    Aul C; Schneider W
    Fortschr Med; 1983 Feb; 101(7):275-82. PubMed ID: 6840654
    [No Abstract]   [Full Text] [Related]  

  • 47. Symposium on leukemia and allied disorders.
    STRAATSMA BR
    Trans Pac Coast Otoophthalmol Soc Annu Meet; 1961; 42():151-3. PubMed ID: 13917579
    [No Abstract]   [Full Text] [Related]  

  • 48. ORGANOTHERAPY IN EXPERIMENTAL LEUKEMIAS.
    FEDOROV NA; ZARETSKY II; RESCHIKOV VP; KHOKHLOVA MP; FERTUKOVA NM; AGEEVA SN
    Acta Unio Int Contra Cancrum; 1964; 20():265-6. PubMed ID: 14151903
    [No Abstract]   [Full Text] [Related]  

  • 49. Monoclonal antibody therapy of leukemias and lymphomas.
    Clark J; Longo D
    J Exp Pathol; 1987; 3(4):319-27. PubMed ID: 3331646
    [No Abstract]   [Full Text] [Related]  

  • 50. Cytotoxic T lymphocytes for leukemia and lymphoma.
    Bollard CM; Barrett AJ
    Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):565-9. PubMed ID: 25696912
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Classification of tumors of the blood systems--hemoblastoses].
    Vorob'ev AI; Chertkov IL; Brilliant MD
    Arkh Patol; 1976; 38(2):9-23. PubMed ID: 1275781
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Treatment of leukemias and lymphomas with interferons: III. Trial treatment of meningeal localizations of acute leukemia and non-Hodgkin's lymphomas with beta interferon administered by the intrathecal route].
    Misset JL; Mathé G; Gastiaburu J; Goutner A; Dorval TI; Gouveia J; Hayat M; Jasmin C; Schwarzenberg L; Machover D; Ribaud P; de Vassal F; Horoszewicz JP
    Biomed Pharmacother; 1982; 36(3):167-70. PubMed ID: 6758874
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Management of lymphomas and leukemias.
    BLOCK M
    Rocky Mt Med J; 1959 Jun; 56(6):59-63. PubMed ID: 13658893
    [No Abstract]   [Full Text] [Related]  

  • 54. Recent advances in the treatment of the leukemias and lymphomas.
    LOEB V; REINHARD EH
    Ariz Med; 1958 Dec; 15(12):876-8. PubMed ID: 13607227
    [No Abstract]   [Full Text] [Related]  

  • 55. The role of the thymus and thymic humoral factors in immunotherapy of aplastic and proliferative diseases of the hemopoietic system.
    Aleksandrowicz J; Skotnicki AB
    Acta Med Pol; 1976; 17(1):1-17. PubMed ID: 769487
    [No Abstract]   [Full Text] [Related]  

  • 56. Neurologic aspects of lymphoma and leukemias.
    McCoyd M; Gruener G; Foy P
    Handb Clin Neurol; 2014; 120():1027-43. PubMed ID: 24365369
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Results in the use of triethylene melamine (TEM) in malignant lymphomas and chronic leukemias.
    MEZA ARRAU C; NIJAMKIN A
    Rev Med Chil; 1955 Feb; 83(2):90-5. PubMed ID: 14385308
    [No Abstract]   [Full Text] [Related]  

  • 58. Skin manifestations of leukemias and lymphomas.
    Stawiski MA
    Cutis; 1978 Jun; 21(6):814-8. PubMed ID: 275026
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
    Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
    Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment of leukemia and allied disorders with folic acid antagonists, effect of aminopterin on skeletal lesions.
    SILVERMAN FN
    Radiology; 1950 May; 54(5):665-78. PubMed ID: 15417758
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.